Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mackiewicz

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Human Gene Therapy|June 1, 1995
Gene therapy of human melanoma. Immunization of patients with autologous tumor cells admixed with allogeneic melanoma cells secreting interleukin 6 and soluble interleukin 6 receptorA Mackiewicz, A Górny, M Laciak, et al.
Immunology Letters|September 21, 2000
Genetically modified tumour vaccines (GMTV) in melanoma clinical trialsS Nawrocki, P Murawa, J Malicki, et al.
Cancer Gene Therapy|March 3, 2001
Antitumor effects of the combination therapy with TNF-alpha gene-modified tumor cells and interleukin 12 in a melanoma model in miceW Lasek, A Mackiewicz, A Czajka, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Immunogene therapy of human melanoma. Phase I/II clinical trialA Mackiewicz, M Kapcińska, M Wiznerowicz, et al.
Advances in Experimental Medicine and Biology|January 5, 2002
Humoral responses to melanoma vaccine, genetically modified with interleukin 6 and soluble interleukin 6 receptorS Nawrocki, M Łaciak, D Izycki, et al.
Journal of Viral Hepatitis|April 19, 2017
HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjectsE Papasavvas, L Azzoni, X Yin, et al.
Glycoconjugate Journal|January 9, 1999
Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in alpha3-fucosylation of alpha1-acid glycoproteinE C Havenaar, J S Axford, E C Brinkman-van der Linden, et al.
Oncogene|November 15, 1997
Novel BRCA1 mutations and more frequent intron-20 alteration found among 236 women from Western PolandK Sobczak, P Kozłowski, M Napierała, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAF<sup>v600</sup> mutation-positive melanoma receiving adjuvant vemurafenibP A Ascierto, K D Lewis, A M Di Giacomo, et al.
Journal of Medical Genetics|May 10, 2005
A common variant of CDKN2A (p16) predisposes to breast cancerT Debniak, B Górski, T Huzarski, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Human Gene Therapy|June 1, 1995
Gene therapy of human melanoma. Immunization of patients with autologous tumor cells admixed with allogeneic melanoma cells secreting interleukin 6 and soluble interleukin 6 receptorA Mackiewicz, A Górny, M Laciak, et al.
Immunology Letters|September 21, 2000
Genetically modified tumour vaccines (GMTV) in melanoma clinical trialsS Nawrocki, P Murawa, J Malicki, et al.
Cancer Gene Therapy|March 3, 2001
Antitumor effects of the combination therapy with TNF-alpha gene-modified tumor cells and interleukin 12 in a melanoma model in miceW Lasek, A Mackiewicz, A Czajka, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Immunogene therapy of human melanoma. Phase I/II clinical trialA Mackiewicz, M Kapcińska, M Wiznerowicz, et al.
Advances in Experimental Medicine and Biology|January 5, 2002
Humoral responses to melanoma vaccine, genetically modified with interleukin 6 and soluble interleukin 6 receptorS Nawrocki, M Łaciak, D Izycki, et al.
Journal of Viral Hepatitis|April 19, 2017
HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjectsE Papasavvas, L Azzoni, X Yin, et al.
Glycoconjugate Journal|January 9, 1999
Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in alpha3-fucosylation of alpha1-acid glycoproteinE C Havenaar, J S Axford, E C Brinkman-van der Linden, et al.
Oncogene|November 15, 1997
Novel BRCA1 mutations and more frequent intron-20 alteration found among 236 women from Western PolandK Sobczak, P Kozłowski, M Napierała, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAF<sup>v600</sup> mutation-positive melanoma receiving adjuvant vemurafenibP A Ascierto, K D Lewis, A M Di Giacomo, et al.
Journal of Medical Genetics|May 10, 2005
A common variant of CDKN2A (p16) predisposes to breast cancerT Debniak, B Górski, T Huzarski, et al.
Pageof 11